Global Immune Repertoire Sequencing Market Size, Status and Forecast 2019-2025

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Immune Repertoire Sequencing Revenue
• 1.4 Market by Type
  • 1.4.1 Global Immune Repertoire Sequencing Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Pyro-Sequencing
  • 1.4.3 Dye-Terminating Sequencing
  • 1.4.4 Semiconductor Sequencing
  • 1.4.5 Others
• 1.5 Market by Application
  • 1.5.1 Global Immune Repertoire Sequencing Market Share by Application: 2020 VS 2026
  • 1.5.2 Biomarker Discovery
  • 1.5.3 Infectious Diseases
  • 1.5.4 Vaccine Development and Efficacy
  • 1.5.5 Cancer Immunotherapy
  • 1.5.6 Autoimmune Disease
  • 1.5.7 Transplant Rejection and Tolerance
  • 1.5.8 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Immune Repertoire Sequencing Market Perspective (2015-2026)
• 2.2 Global Immune Repertoire Sequencing Growth Trends by Regions
  • 2.2.1 Immune Repertoire Sequencing Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Immune Repertoire Sequencing Historic Market Share by Regions (2015-2020)
  • 2.2.3 Immune Repertoire Sequencing Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Immune Repertoire Sequencing Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Immune Repertoire Sequencing Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Immune Repertoire Sequencing Players by Market Size
  • 3.1.1 Global Top Immune Repertoire Sequencing Players by Revenue (2015-2020)
  • 3.1.2 Global Immune Repertoire Sequencing Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Immune Repertoire Sequencing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Immune Repertoire Sequencing Market Concentration Ratio
  • 3.2.1 Global Immune Repertoire Sequencing Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Immune Repertoire Sequencing Revenue in 2019
• 3.3 Immune Repertoire Sequencing Key Players Head office and Area Served
• 3.4 Key Players Immune Repertoire Sequencing Product Solution and Service
• 3.5 Date of Enter into Immune Repertoire Sequencing Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Immune Repertoire Sequencing Historic Market Size by Type (2015-2020)
• 4.2 Global Immune Repertoire Sequencing Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Immune Repertoire Sequencing Market Size by Application (2015-2020)
• 5.2 Global Immune Repertoire Sequencing Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Immune Repertoire Sequencing Market Size (2015-2020)
• 6.2 Immune Repertoire Sequencing Key Players in North America (2019-2020)
• 6.3 North America Immune Repertoire Sequencing Market Size by Type (2015-2020)
• 6.4 North America Immune Repertoire Sequencing Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Immune Repertoire Sequencing Market Size (2015-2020)
• 7.2 Immune Repertoire Sequencing Key Players in Europe (2019-2020)
• 7.3 Europe Immune Repertoire Sequencing Market Size by Type (2015-2020)
• 7.4 Europe Immune Repertoire Sequencing Market Size by Application (2015-2020)

8 China

• 8.1 China Immune Repertoire Sequencing Market Size (2015-2020)
• 8.2 Immune Repertoire Sequencing Key Players in China (2019-2020)
• 8.3 China Immune Repertoire Sequencing Market Size by Type (2015-2020)
• 8.4 China Immune Repertoire Sequencing Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Immune Repertoire Sequencing Market Size (2015-2020)
• 9.2 Immune Repertoire Sequencing Key Players in Japan (2019-2020)
• 9.3 Japan Immune Repertoire Sequencing Market Size by Type (2015-2020)
• 9.4 Japan Immune Repertoire Sequencing Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Immune Repertoire Sequencing Market Size (2015-2020)
• 10.2 Immune Repertoire Sequencing Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Immune Repertoire Sequencing Market Size by Type (2015-2020)
• 10.4 Southeast Asia Immune Repertoire Sequencing Market Size by Application (2015-2020)

11 India

• 11.1 India Immune Repertoire Sequencing Market Size (2015-2020)
• 11.2 Immune Repertoire Sequencing Key Players in India (2019-2020)
• 11.3 India Immune Repertoire Sequencing Market Size by Type (2015-2020)
• 11.4 India Immune Repertoire Sequencing Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Immune Repertoire Sequencing Market Size (2015-2020)
• 12.2 Immune Repertoire Sequencing Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Immune Repertoire Sequencing Market Size by Type (2015-2020)
• 12.4 Central & South America Immune Repertoire Sequencing Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 ArcherDX
  • 13.1.1 ArcherDX Company Details
  • 13.1.2 ArcherDX Business Overview
  • 13.1.3 ArcherDX Immune Repertoire Sequencing Introduction
  • 13.1.4 ArcherDX Revenue in Immune Repertoire Sequencing Business (2015-2020))
  • 13.1.5 ArcherDX Recent Development
• 13.2 Junom Therapeutics
  • 13.2.1 Junom Therapeutics Company Details
  • 13.2.2 Junom Therapeutics Business Overview
  • 13.2.3 Junom Therapeutics Immune Repertoire Sequencing Introduction
  • 13.2.4 Junom Therapeutics Revenue in Immune Repertoire Sequencing Business (2015-2020)
  • 13.2.5 Junom Therapeutics Recent Development
• 13.3 Roche Holding
  • 13.3.1 Roche Holding Company Details
  • 13.3.2 Roche Holding Business Overview
  • 13.3.3 Roche Holding Immune Repertoire Sequencing Introduction
  • 13.3.4 Roche Holding Revenue in Immune Repertoire Sequencing Business (2015-2020)
  • 13.3.5 Roche Holding Recent Development
• 13.4 Illumina
  • 13.4.1 Illumina Company Details
  • 13.4.2 Illumina Business Overview
  • 13.4.3 Illumina Immune Repertoire Sequencing Introduction
  • 13.4.4 Illumina Revenue in Immune Repertoire Sequencing Business (2015-2020)
  • 13.4.5 Illumina Recent Development
• 13.5 ThermoFisher Scietific
  • 13.5.1 ThermoFisher Scietific Company Details
  • 13.5.2 ThermoFisher Scietific Business Overview
  • 13.5.3 ThermoFisher Scietific Immune Repertoire Sequencing Introduction
  • 13.5.4 ThermoFisher Scietific Revenue in Immune Repertoire Sequencing Business (2015-2020)
  • 13.5.5 ThermoFisher Scietific Recent Development
• 13.6 Pacific Biosciences
  • 13.6.1 Pacific Biosciences Company Details
  • 13.6.2 Pacific Biosciences Business Overview
  • 13.6.3 Pacific Biosciences Immune Repertoire Sequencing Introduction
  • 13.6.4 Pacific Biosciences Revenue in Immune Repertoire Sequencing Business (2015-2020)
  • 13.6.5 Pacific Biosciences Recent Development
• 13.7 CD Genomics
  • 13.7.1 CD Genomics Company Details
  • 13.7.2 CD Genomics Business Overview
  • 13.7.3 CD Genomics Immune Repertoire Sequencing Introduction
  • 13.7.4 CD Genomics Revenue in Immune Repertoire Sequencing Business (2015-2020)
  • 13.7.5 CD Genomics Recent Development
• 13.8 Atreca
  • 13.8.1 Atreca Company Details
  • 13.8.2 Atreca Business Overview
  • 13.8.3 Atreca Immune Repertoire Sequencing Introduction
  • 13.8.4 Atreca Revenue in Immune Repertoire Sequencing Business (2015-2020)
  • 13.8.5 Atreca Recent Development
• 13.9 Adaptive Biotechnologies
  • 13.9.1 Adaptive Biotechnologies Company Details
  • 13.9.2 Adaptive Biotechnologies Business Overview
  • 13.9.3 Adaptive Biotechnologies Immune Repertoire Sequencing Introduction
  • 13.9.4 Adaptive Biotechnologies Revenue in Immune Repertoire Sequencing Business (2015-2020)
  • 13.9.5 Adaptive Biotechnologies Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer